Streetbeat News

Stock Prices

OUST

Ouster Inc (NYSE: OUST) shares surged after executives disclosed insider stock purchases. President and CEO Angus Charles Pacala and CTO Mark Frichtl bought significant shares, signaling confidence in the company's future. Ouster, a provider of LiDAR sensors, saw a 102.98% revenue growth over the past year.

Portfolio Pulse from Vaishali Prayag

May 17, 2024 | 7:35 pm

SAVA

Cassava Sciences shares are trading higher after HC Wainwright maintained a Buy rating on the stock and raised its price target from $124 to $131.

Portfolio Pulse from Benzinga Newsdesk

May 17, 2024 | 7:34 pm

ALNY

Alnylam Pharmaceuticals (NYSE:ALNY) has seen a 4.82% increase in its short percent of float, now at 2.39% of all regular shares available for trading. This indicates a rise in bearish sentiment, although the company's short interest is still below the peer group average of 6.12%.

Portfolio Pulse from Benzinga Insights

May 17, 2024 | 7:30 pm

HCA

HCA Healthcare (NYSE:HCA) has significantly outperformed the market over the past 10 years, delivering an average annual return of 19.92%. A $1000 investment in HCA stock 10 years ago would be worth $6,157.84 today. The article highlights the impact of compounded returns on long-term investment growth.

Portfolio Pulse from Benzinga Insights

May 17, 2024 | 7:30 pm

BOOT

Boot Barn Holdings (NYSE:BOOT) has significantly outperformed the market over the past 10 years, delivering an average annual return of 20.58%. A $100 investment in BOOT stock 10 years ago would now be worth $649.86. The company's current market capitalization is $3.45 billion.

Portfolio Pulse from Benzinga Insights

May 17, 2024 | 7:30 pm

KOSS

Koss (NYSE:KOSS) has seen a 4.55% increase in its short percent of float, now at 0.23% of all regular shares available for trading. This indicates a rise in bearish sentiment among investors. However, Koss's short interest is still lower than its peer group average of 5.79%.

Portfolio Pulse from Benzinga Insights

May 17, 2024 | 7:30 pm

TLRY

Tilray Brands shares are trading lower after the company announced an at-the-market program to fund acquisitions.

Portfolio Pulse from Benzinga Newsdesk

May 17, 2024 | 7:28 pm

ERAS

Erasca shares are trading higher following the announcement of exclusive license agreements for two preclinical RAS programs.

Portfolio Pulse from Benzinga Newsdesk

May 17, 2024 | 7:22 pm

AMGN

Significant unusual options activity has been observed for Amgen (NASDAQ:AMGN), with a mix of bullish and bearish trades. The options activity suggests a focus on a price range between $280 and $325. Analysts have mixed ratings on the stock, with target prices ranging from $235 to $328.

Portfolio Pulse from Benzinga Insights

May 17, 2024 | 7:16 pm

CVS

Financial giants have made bearish moves on CVS Health, with 58% of recent options trades being bearish. The price range for CVS is predicted to be between $40.0 and $57.5. Current market status shows CVS down -0.24% at $57.38, with RSI indicators suggesting it may be oversold. Analysts have mixed ratings, with a consensus target price of $66.0.

Portfolio Pulse from Benzinga Insights

May 17, 2024 | 7:16 pm